Detalhe da pesquisa
1.
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid.
Mol Cancer;
22(1): 178, 2023 11 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37932736
2.
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients.
Biomark Res;
11(1): 93, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37858195
3.
Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer.
Clin Cancer Res;
29(16): 3124-3129, 2023 08 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37067532
4.
The Identification of Large Rearrangements Involving Intron 2 of the CDH1 Gene in BRCA1/2 Negative and Breast Cancer Susceptibility.
Genes (Basel);
13(12)2022 11 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36553480